IL1B and type 2 diabetes mellitus: Releasing IL-1Ra fixation leads to a restoration of the T2D state associated with accelerated loss of β-cell mass (Fig. 7B, black square), because the stable pre-diabetic steady state associated with low IL-1β is not restored by this therapy (Fig. 7B).